Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative randomized double-blind trial of sevoflurane plus remifentanil for insertion of LM-Supreme vs LM-Proseal
2012-004163-50Phase 4Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario La Paz
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sevoflurane (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario La Paz. Primary endpoint: Required end-tidal sevoflurane concentration for LM-Supreme vs LM-Proseal insertion. Started Feb 2014; status: completed.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on 2012-004163-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004163-50.